While both populations express PD-L1 and PD-L2, the percentage of positive cells and the MFI for these two inhibitory molecules were significantly higher within the CD103- population following tumor development (Fig 2D, 2F and 2G). The gene discussed is ITGAE; the disease is neoplasm.